<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>IPRBrew</title><description>Your daily cup of IPR news, brewed, filtered and served.</description><link>https://iprbrew.com/</link><item><title>The Ozempic Wars: How Novo Nordisk Fought India&apos;s Dr Reddy&apos;s on Two Fronts — and Why It Matters</title><link>https://iprbrew.com/posts/novo-nordisk-vs-dr-reddys-ozempic-olymviq/</link><guid isPermaLink="true">https://iprbrew.com/posts/novo-nordisk-vs-dr-reddys-ozempic-olymviq/</guid><description>A patent clash, a confusingly named drug, and a judge who chose public interest over destruction — the Novo Nordisk vs Dr Reddy&apos;s saga explained.</description><pubDate>Sun, 05 Apr 2026 09:00:00 GMT</pubDate></item></channel></rss>